We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
The Tycoon Herald
  • Trending
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Money
    • Crypto / NFT
  • Innovation
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Leadership
  • Health
  • Sports
  • Entertainment
Reading: Black Diamond Therapeutics to Host Webcast Presentation of Preliminary Part 2 BDTX-1535 Information in Sufferers With Recurrent EGFRm NSCLC By Investing.com
Sign In
The Tycoon HeraldThe Tycoon Herald
Font ResizerAa
Search
  • Trending
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Money
    • Crypto / NFT
  • Innovation
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Leadership
  • Health
  • Sports
  • Entertainment
Have an existing account? Sign In
Follow US
© Tycoon Herald. All Rights Reserved.
Black Diamond Therapeutics to Host Webcast Presentation of Preliminary Part 2 BDTX-1535 Information in Sufferers With Recurrent EGFRm NSCLC By Investing.com
The Tycoon Herald > Business > Black Diamond Therapeutics to Host Webcast Presentation of Preliminary Part 2 BDTX-1535 Information in Sufferers With Recurrent EGFRm NSCLC By Investing.com
Business

Black Diamond Therapeutics to Host Webcast Presentation of Preliminary Part 2 BDTX-1535 Information in Sufferers With Recurrent EGFRm NSCLC By Investing.com

Tycoon Herald
By Tycoon Herald 2 Min Read
Share
SHARE

Black Diamond Therapeutics to Host Webcast Presentation of Preliminary Part 2 BDTX-1535 Information in Sufferers With Recurrent EGFRm NSCLC By Investing.com

Webcast to be held Monday, September 23, at 8:00 a.m. ET

CAMBRIDGE, Mass., Sept. 22, 2024 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: NASDAQ:), a clinical-stage oncology firm creating MasterKey therapies that focus on households of oncogenic mutations in sufferers with most cancers, will host a webcast to reveal preliminary part 2 medical trial outcomes for BDTX-1535 in sufferers with recurrent EGFRm NSCLC on Monday, September 23, 2024, at 8:00am ET.

Webcast info

The webcast could be accessed underneath Occasions and Displays on the Traders part of the Black Diamond web site at  www.blackdiamondtherapeutics.com. A replay of the webcast might be out there following the completion of the occasion.

About Black Diamond Therapeutics

Black Diamond Therapeutics is a clinical-stage oncology firm creating MasterKey therapies that focus on households of oncogenic mutations in sufferers with most cancers. The Firm’s MasterKey therapies are designed to handle a broad spectrum of genetically outlined tumors, overcome resistance, decrease wild-type mediated toxicities, and be mind penetrant to deal with CNS illness. The Firm is advancing two clinical-stage applications: BDTX-1535, a brain-penetrant fourth-generation EGFR MasterKey inhibitor concentrating on EGFR mutant NSCLC and GBM, and BDTX-4933, a brain-penetrant RAF MasterKey inhibitor concentrating on KRAS, NRAS and BRAF alterations in strong tumors. For extra info, please go to www.blackdiamondtherapeutics.com.

Contacts

For Traders:
Mario Corso, Head of Investor Relations, Black Diamond Therapeutics
[email protected]

For Media:
[email protected]

You Might Also Like

Joseph Safina’s Driven Becomes Amazon Bestseller, Blending High Finance with High Speeds

Fashion Designer Hyeonseo Irene Park: Redefining Menswear Through Originality and Collaboration

From Pattaya to the World: Bryan Flowers’ Unstoppable Rise as a Global Entrepreneur

Astana International Forum 2025: “Connecting Minds, Shaping the Future”

Investment success: GP Fatih Marketing Research Co LLC and the gold dream in Africa

TAGGED:BDTX1535BlackdatadiamondEGFRmhostinitialInvesting.comNSCLCpatientsPhasePresentationRecurrentTherapeuticsWebcast
Share This Article
Facebook Twitter Email Copy Link Print
Tyler Dibling switch information: Everton full £42m deal to signal Southampton winger to take summer season spend complete to £124m
Sports

Tyler Dibling switch information: Everton full £42m deal to signal Southampton winger to take summer season spend complete to £124m

Everton have accomplished the signing of teenage winger Tyler Dibling from Southampton in a deal value £42m.Sky Sports activities Information understands the deal contains £6m value of easily-achievable add-ons and…

By Tycoon Herald 7 Min Read
*NSYNC’s JC Chasez Attends Backstreet Boys Present in Las Vegas
August 26, 2025
Jack Draper: US Open first-round win ‘wasn’t my most interesting efficiency’ however injured left arm ‘responded superb’
August 26, 2025
Evergrande’s delisting in Hong Kong: key details to know
August 25, 2025
Emmanuel Haro’s Mother Standing by Kidnapping Story After Arrest
August 25, 2025

You Might Also Like

Gaza residents stream dwelling to the north after hostage breakthrough By Reuters
Business

Gaza residents stream dwelling to the north after hostage breakthrough By Reuters

By Tycoon Herald 6 Min Read
Greenback positive factors on tariffs fears; euro seems to be to ECB assembly By Investing.com
Business

Greenback positive factors on tariffs fears; euro seems to be to ECB assembly By Investing.com

By Tycoon Herald 5 Min Read
EQT Real Estate acquires 12-building logistics assemblage positioned in key Northern Italian submarkets By Investing.com
Business

EQT Real Estate acquires 12-building logistics assemblage positioned in key Northern Italian submarkets By Investing.com

By Tycoon Herald 4 Min Read

More Popular from Tycoon Herald

MEET THE FATHER OF COADUNATE ECONOMIC MODEL
BusinessTrending

MEET THE FATHER OF COADUNATE ECONOMIC MODEL

By Tycoon Herald 2 Min Read
Woman Sentenced to 7 Days in Jail for Walking in Yellowstone’s Thermal Area

Woman Sentenced to 7 Days in Jail for Walking in Yellowstone’s Thermal Area

By Tycoon Herald
Empowering Fintech Innovation: Swiss Options Partners with Stripe to Transform Digital Payments
InnovationTrending

Empowering Fintech Innovation: Swiss Options Partners with Stripe to Transform Digital Payments

By Tycoon Herald 7 Min Read
Sports

Chelsea transfers: Celtic’s Matt O’Riley a possible substitute for Conor Gallagher

​​​​​​​Chelsea are assessing potential replacements ought to Conor Gallagher depart the membership. Sky Sports activities Information understands certainly one of…

By Tycoon Herald
Entertainment

‘Stranger Issues’ Star Gaten Matarazzo Hoping To Get Present Wrapped ASAP

Play video content material BACKGRID Gaten Matarazzo's pushing for "Stranger Things" to choose up the tempo…

By Tycoon Herald
Trending

U.S. Blew Up a C.I.A. Post Used to Evacuate At-Risk Afghans

A controlled detonation by American forces that was heard throughout Kabul has destroyed Eagle Base, the…

By Tycoon Herald
Leadership

Northern Lights: 17 Best Places To See Them In 2021

Who doesn’t dream of seeing the northern lights? According to a new survey conducted by Hilton, 59% of Americans…

By Tycoon Herald
Real Estate

Exploring Bigfork, Montana: A Little Town On A Big Pond

Bigfork, Montana, offers picturesque paradise in the northern wilderness. National Parks Realty With the melting of…

By Tycoon Herald
Leadership

Leaders Need To Know Character Could Be Vital For Corporate Culture

Disney's unique culture encourages young employees to turn up for work with smiles on their faces.…

By Tycoon Herald
The Tycoon Herald

Tycoon Herald: Your instant connection to breaking stories and live updates. Stay informed with our real-time coverage across politics, tech, entertainment, and more. Your reliable source for 24/7 news.

Company

  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • WP Creative Group
  • Accessibility Statement

Contact Us

  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability

Terms of Use

  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© Tycoon Herald. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?